The purpose of this study was to use the microarray technology to define expression profiles characteristic of thyroid autonomous adenomas and relate these findings to physiological mechanisms. Experiments were performed on a series of separated adenomas and their normal counterparts on Micromax cDNA microarrays covering 2400 genes (analysis I), and on a pool of adenomatous tissues and their corresponding normal counterparts using microarrays of 18 000 spots (analysis II). Results for genes present on the two arrays corroborated and several gene regulations previously determined by Northern blotting or microarrays in similar lesions were confirmed. Five overexpressed and 24 underexpressed genes were also confirmed by real-time RT-PCR in some of the samples used for microarray analysis, and in additional tumor specimens. Our results show: (1) a change in the cell populations of the tumor, with a marked decrease in lymphocytes and blood cells and an increase in endothelial cells. The latter increase would correspond to the establishment of a close relation between thyrocytes and endothelial cells and is related to increased N-cadherin expression. It explains the increased blood flow in the tumor; (2) a homogeneity of tumor samples correlating with their common physiopathological mechanism: the constitutive activation of the thyrotropin (TSH)/cAMP cascade; (3) a low proportion of regulated genes consistent with the concept of a minimal deviation tumor; (4) a higher expression of genes coding for specific functional proteins, consistent with the functional hyperactivity of the tumors; (5) an increase of phosphodiesterase gene expression which explains the relatively low cyclic AMP levels measured in these tumors; (6) an overexpression of antiapoptotic genes and underexpression of proapoptotic genes compatible with their low apoptosis rate; (7) an overexpression of N-cadherin and downregulation of caveolins, which casts doubt about the use of these expressions as markers for malignancy.
Introduction
Autonomous thyroid adenomas are monoclonal encapsulated benign tumors that grow, metabolize iodide, and secrete thyroid hormones independently of the normal thyrotropin (TSH) control, the main proliferative and functional stimulus of the thyroid gland (Corvilain et al., 2001) . They can be either solitary or part of a multinodular goiter, and grow rather slowly. Their frequency is an inverse function of the iodine dietary supply, and they are therefore uncommon in the USA or in Japan, but very common in Europe (Knudsen et al., 2000; Tonacchera et al., 2000; Dremier et al., 2002) . Their autonomous secretion of thyroid hormones decreases TSH secretion by the classical negative feedback exerted on the pituitary thyrotrophs and on TRH secretion. This leads to functional quiescence of the nonaffected tissue. If untreated, in the presence of sufficient iodine supply to allow the synthesis and secretion of excess thyroid hormones and once they reach a certain size, autonomous adenomas cause hyperthyroidism (Ermans and Camus, 1972; Corvilain et al., 2001) . They therefore represent a major medical problem and account for about half of the cases of hyperthyroidism in Europe (Russo et al., 1995; Bauch, 1998; Corvilain et al., 2001) . Clinically, they are diagnosed by the presence of hot nodules that take up high amounts of radioiodide or 99m Tc pertechnetate, and are surrounded by poorly radioactive quiescent tissue, and by low TSH serum levels, with normal or elevated thyroid hormone levels. Their histology represents a mixture in various proportions of micro-and macrofollicles surrounded by a well-defined capsula. The majority have a monoclonal origin (Namba et al., 1990; Krohn et al., 1998) . A very minor proportion may degenerate into malignant follicular carcinomas, whereas a much higher proportion of cold (i.e. noniodide trapping) follicular adenomas do.
TSH exerts most of its effects via a seven-transmembrane domain receptor positively coupled to adenylate cyclase, leading to a rise in intracellular cAMP levels (Dremier et al., 2002) . In Europe and Japan, one of the main mechanisms responsible for the hyperfunction and growth of thyroid autonomous adenomas is the constitutive activation of the cAMP-dependent mitogenic cascade, through mutations conferring constitutive activity of the TSH receptor (50-80%) or an activating mutation of G sa (8%) (Russo et al., 1995; Van Sande et al., 1995; Fuhrer et al., 1997; Tonacchera et al., 1999; Vanvooren et al., 2002) . Similar mutations account for hyperfunctioning nodules in multinodular goiters (Tonacchera et al., 1999 (Tonacchera et al., , 2000 Krohn et al., 2000) . Their phenotype is reproduced in transgenic mice expressing the constitutive adenosine A2 receptor (Ledent et al., 1992) , constitutive G sa (Michiels et al., 1994) or the activator of G sa choleratoxin (Zeiger et al., 1997) . Autonomous adenomas are thus a well-defined example of the results of long-term stimulation by the physiological TSH receptor/cAMP-dependent cascade of human thyroid tissue in vivo (Dumont et al., 1989) . As such, they illustrate the concept of minimal deviation tumors: they are constituted of hyperfunctioning thyroid cells whose operation is uncoupled from their normal physiological control (Van Sande et al., 1988; Weber, 2002) . However, data are scarce about specific gene expression modifications in these tumors and especially about their physiopathological consequences.
Numerous studies in different tumor types have shown that gene expression profiling of clinical samples by microarray offers unprecedented opportunities to obtain molecular signatures of the state of the tumors. In this study, we have analysed the pattern of gene expression in hyperfunctioning autonomous thyroid adenomas and validated the relative expression of selected genes by real-time RT-PCR. The data show that several physiological and morphological characteristics of these adenomas can be explained by their transcriptional program.
Results
Two types of analyses were performed: an analysis of gene expression in separated, individual samples of adenomatous and adjacent tissues (analysis I), and a general survey of gene expression on a large number of genes, for which a pool of equal amounts of RNA from adenoma or normal adjacent tissues from five patients were compared (analysis II). Among these patients, two had been treated with antithyroid drugs (v4, a15). The two pooled RNA preparations were also used as pooled samples for real-time RT-PCR analysis. For analysis I, we used the Micromax cDNA system (PerkinElmer) and analysed 13 patients, two of them being treated (v4, a15) . Among the 13 adenomas, eight were solitary, while five were from a multinodular goiter. Three patients were common to analysis I and analysis II.
Adenomas were identified by scintigraphy and in some cases by a higher in vitro iodide uptake than the control quiescent tissue. The analysed tissue RNAs were validated for untreated patients by a NIS RNA expression higher than in control tissues, as evaluated by RT-PCR (see below). For control purposes, one multinodular goiter with no hyperfunctioning adenoma (v6) was compared to normal adjacent tissue. For serial real-time RT-PCR analysis, 10 samples from 10 new patients, all of them untreated, were analysed.
Analysis of separated samples (analysis I)
Reproducibility of the TSA method in gene expression analysis Tyramide signal amplification in microarray gene expression is a very useful method when limiting amounts of RNA are available. To assess its reproducibility, we labeled reverse-transcribed total RNA from the adenomatous tissue with biotin and total RNA from the control tissue with fluorescein. We performed hybridization with the reverse combination of dyes as well (dye swap), and calculated the averages of the intensity ratios obtained with the two opposite dye combinations (tumor/control) (Taniguchi et al., 2001; Karsten et al., 2002) . A high correlation (96%) between the ratios of the intensity values was obtained for duplicate spots on the same array. When comparing the same spot on two different slides, correlation ranged between 70 and 80%. With microarray data generated by two independent RNA preparations from the same tumor sample (a11/v3), a correlation of 73% was obtained (data not shown). We thus concluded that tyramide signal amplification is a consistent and reproducible method, adequate for our analyses.
Gene expression analysis shows high homogeneity between different autonomous adenomas For each adenoma/ control paired sample, experiments were duplicated with dye switching, and the averages of the intensity ratios (tumor/control) resulting from each dye combination were calculated. A total of 14 tumor samples were analysed (Table 1) . We performed unsupervised hierarchical clustering of the samples to analyse the data. As depicted in Figure 1 , a set of up-or downregulated genes could be identified, with similar expression in the majority of the tumors, suggesting that thyroid adenomas are relatively homogeneous tissues, based on gene expression analysis. However, tumor classification allowed us to distinguish a subset of samples, underlined in blue (v1-a21), clustered more closely. The samples that were on the most distant dendrogram branches were samples v4, a15 and v6. Sample v6, the multinodular goiter included as a control, clusters apart from the adenoma samples.
We further examined the clinical data from these patients, listed in Table 1 , to explore the possibility of a relationship between the dendrogram branching pattern and one or several pathological features. We could find a relationship between the dendrogram pattern and the capacity of the tumor to transport iodide. Iodide transport has been quantitated previously in the Figure 1 Hierarchical clustering of the microarray data from 14 thyroid tumor samples and identification of a subset of tumors (underlined in blue). The results represent the averages of the intensity ratios (tumor/control) resulting from each dye combination, and the genes considered are those with a median intensity >1 (B1200 genes). Each row represents a cDNA clone and each column a tumor RNA sample. Red indicates upregulation, green downregulation and black no change, according to the color scale shown. Two clusters, one indicating an upregulation of mitochondrial genes and the other a downregulation of transcription factors, are indicated laboratory and was significantly higher in the adenomatous tissues than in the quiescent tissues in the group of samples which clustered more tightly, but was comparable between normal and tumor tissue slices for samples v4 and a15 of patients under methimazole treatment. Thus, the subset of tumors which cluster together are also those which are characterized by a high rate of iodide transport, that is, the highest hyperactivity with regard to iodide uptake. In accordance with this hyperactivity, NIS mRNA expression was shown to be increased in all the untreated autonomous adenomas, as revealed by real-time RT-PCR ( Figure 2 ) and previously by Northern blotting (Deleu et al., 2000) . As expected for patients v4 and a15, under methimazole treatment, adenomatous and normal tissues express NIS mRNA equally. Hierarchical clustering of the genes groups genes encoding mitochondrial proteins and immediate early genes in the upper and lower parts of the panel, respectively (Figure 1 ). A clustering of such genes has been previously demonstrated in oncocytomas (Baris et al., 2004) and in papillary thyroid carcinomas (Haugen et al., 2003) .
We then focused on gene expression differences between normal and tumor tissues. Genes with greater than twofold and statistically significant differential expression (Po0.05, among all the investigated tumors) were identified: 11 genes were overexpressed and 22 genes were underexpressed in most of the adenomas. These genes were included in the results of the general survey described below (Table 2) .
General survey of gene expression (analysis II)
In a second approach, tumor RNA extracts from five adenoma samples were pooled and hybridized with their respective control pools on microarrays containing 18 442 ESTs representing 13 000 human genes spotted in duplicate. A dye-swap hybridization was performed, and the few genes for which the color flip gave different results were not considered. Considering up-or downregulation expression ratios >2 and levels of expression above the first 25%, 348 genes were upregulated and 364 downregulated. For expression ratios >3 in the 75% most expressed genes, 74 were upregulated and 100 downregulated (Table 2a and b) , where the genes are classified according to Gene Ontology (http://fatigo. bioinfo.cnio.es).
The following genes were found to be significantly overexpressed in both the separated pairs of samples (analysis I) and in the pooled samples (analysis II): MT1, FcGBP and CKB.
The following genes were found to be significantly downregulated in both analysis I and II: clusterin, bcd (COPEB), ATF3, cav1, DUSP1, junB, DNAJ, TR3 (NR4A1 or NGFIB), fibulin1 and C1s.
Quite a few upregulations confirm previously obtained data: thyroperoxidase (Deleu et al., 2000) , deiodinase (dio1), sialylyltransferase, protein kinase C b , collagen IV and IX (Eszlinger et al., 2004) . FcGBP has been shown to be upregulated in follicular adenomas (O'Donovan et al., 2002) . Alcohol DH (Eszlinger et al., 2004) and solute carrier expressions are also increased in the Tg-A2aR mice thyroids, an animal model of autonomous adenomas (Goffard et al., 2004) . Phosphodiesterase expression is classically increased in response to cAMP and PKA activation (Cho-Chung, 2004) . Some other gene expressions increased by a factor between 2 and 3, such as wnt, PGF, fibromodullin and ZNF transcription factors, are also increased in TgA2aR mice thyroids (Goffard et al., 2004) or in other cAMP-stimulated tissues (phosphodiesterases) (Lania et al., 1998) . Overexpression of GAPDH has been shown to be induced by TSH in thyroid cell cultures (Savonet et al., 1997) .
Decreased expression of several genes confirms previous data obtained in our group and by others: ApoD, myosin (Eszlinger et al., 2004) , c-fos, fosB, junB, c-myc and TR3 (NGFIB) (Deleu et al., 2000) . Several genes are downregulated in both analysis I and II, but only by a factor of less than 3 in analysis II, namely clusterin, bcd, ATF3, cav1, DUSP1, junB and TR3. Clusterin is also downregulated by TSH in human thyrocytes in culture (Yamazaki et al., 2003) . MT1L and MT1H, a metallothionein called MTIl in analysis I and MT2H in analysis II, but which because of high Gene expression in thyroid autonomous adenomas S Wattel et al Gene expression in thyroid autonomous adenomas S Wattel et al Gene expression in thyroid autonomous adenomas S Wattel et al sequence homology could be the same gene, is upregulated in both series.
Validation of microarray data by real-time RT-PCR
To validate the microarray data, we evaluated the expression of the transcripts in some of the samples initially used for microarray analyses, and in 10 additional pairs of tumor and control adjacent tissue specimens, using real-time RT-PCR. For each sample, hyperactivity was first verified by evaluating NIS mRNA overexpression (Figure 2 ). We normalized expression of all the transcripts to porphobilinogen deaminase (PBGD), which was shown to have similar expression in thyroid adenoma and normal tissue, and to be not regulated by TSH in cultured thyrocytes (unpublished observations). The real-time RT-PCR data were also confirmed using CNAP1 (a gene identified as nonregulated from the microarray results, analysis I) for normalization (not shown). Results are The genes, with expression ratio (tumor/normal) >3 and intensity >25% for the pooled samples analysis, or with ratio >2 for the separated samples analysis, were classified based on their gene ontology function. Genes with * were confirmed by real-time RT-PCR shown in Figure 3 . A moderate (factor 2) underexpression of IGF1 in the pooled samples (analysis II) was confirmed by real-time PCR on separated samples. Whereas CDH2 and TPO were similarly upregulated in each autonomous adenoma tested, FGFR3, S100a1 and CKB were only upregulated in six, seven or nine out of 10 samples, respectively. Among the downregulated genes, egr1, egr2 and lumican were downregulated in all independent samples, as evaluated by RT-PCR (10/10), but the others were downregulated only in the majority of the samples (in at least in seven out of 10 samples).
There was generally a good agreement between the microarray and the real-time RT-PCR data, when considering the expression ratio adenoma/adjacent tissue, as obtained from different methods (Figure 3c and d): microarray data on pooled RNA samples (analysis II) or averaged from separated samples (analysis I), and real-time RT-PCR data on pooled RNA samples or averaged from individual samples.
Western blotting and immunohistochemistry data confirm the differential expression of N-cadherin (CDH2) and caveolin 1 (cav1)
We then focused on the upregulation of CDH2, and on the downregulation of cav1. Protein expression was assessed by Western blotting in five pairs of adenoma/ adjacent tissues, and the results obtained confirmed the RNA expression (Figure 4) .
The overexpression of N-cadherin and decreased expression of cav1 in follicular thyroid cells were subsequently confirmed by immunohistochemistry on tissue microarrays ( Figure 5 ). N-cadherin was present as a weak or stronger lining at the cellular border in the hyperfunctioning autonomous adenoma, and in one case also as a brown cytoplasmic staining, whereas no staining was observed in the control adjacent tissues (Figure 5a ). For cav1, detection underlines more intensely the endothelial cells of the capillaries in the adenomas. However, there was a granular scattered brown immunostaining of the follicular cells in the adenoma contrasting with a stronger cytoplasmic staining of the follicular cells of the adjacent quiescent tissue (Figure 5b ).
Discussion
In this study, we have analysed by two different cDNA microarray technologies gene expression in a welldefined benign thyroid tumor, the hyperfunctioning autonomous adenoma. While several groups have reported gene expression profiles in follicular adenomas and in follicular and papillary carcinomas (Huang et al., 2001; Aldred et al., 2003; Barden et al., 2003; Yano et al., 2004) , only one similar study has been performed so far (Eszlinger et al., 2004) . Our data set provides considerable new information about proteins and pathways involved in this disease, which will now be the subject of more detailed investigations. Among these genes, five, ANXA1, clusterin, creatine kinase B, MT1X and FcGBP, have already been described as part of a sixgenes expression signature allowing to discriminate between autonomous adenomas and papillary thyroid carcinomas (Detours et al., 2005) .
Several lines of evidence support the validity of our analyses (see results). First, where the two microarray analyses overlap, their results are similar, even though different samples and different arrays and protocols for samples processing were used. Second, we confirmed several regulations already identified previously (Deleu et al., 2000; Eszlinger et al., 2001 Eszlinger et al., , 2004 O'Donovan et al., 2002; Finley et al., 2004; Mazzanti et al., 2004; Detours et al., 2005) . Moreover, several findings are in line with data obtained in different but related systems such as thyroid cells or other cells chronically stimulated by the cAMP pathway (Yamazaki et al., 2003) . Third, a significant proportion of the microarray data have been confirmed by real-time RT-PCR. Fourth, as will be further elaborated in the discussion, the pattern of our findings provides a comprehensive physiological framework, which demonstrates for the first time, or confirms and explains, diverse and sometimes apparently unrelated data.
Unsupervised hierarchical clustering of the samples shows that autonomous adenomas are relatively homogeneous tumors, despite tissue microscopic heterogeneity reflecting the presence of follicles of different sizes and apparent activity and of fibrotic elements in the capsula or within the adenoma. This is consistent with the clonality of these lesions and their common physiopathological mechanism: the constitutive activation of the cAMP-dependent mitogenic pathway.
Interestingly, the tumors which clustered the closest, that is, which are molecularly the most similar, are also the ones which were characterized by the highest rate of iodide uptake. This hyperactivity (or higher expression of NIS mRNA) is considered as the best criterion in the identification of autonomous adenomas (Van Sande et al., 1988) . Depending on the size of the lesion and on the level of iodine dietary supply, these adenomas may cause hyperthyroidism or not, explaining why some patients of this group have normal thyroid hormone levels despite hyperactivity of their tumor.
Differences in the pattern of gene expressed in tumors and in normal tissue are often interpreted as differences between tumor cells and normal cells. Although this is valid for leukemias and other liquid tumors, in which almost pure tumor cells are compared to their normal counterparts, it is not for solid tumors and tissues in which the proportion of different cell types may be very different (Venet et al., 2001) . Several major findings on gene expression reflect such differences. The most Gene expression in thyroid autonomous adenomas S Wattel et al striking finding is the important downregulation of lymphocyte specific genes. It is well known by pathologists that follicular adenomas contain few lymphocytes and this decrease has been previously reported (Aust et al., 2001) . A similar reduction has been described in the thyroids of Tg-A2aR mice (Goffard et al., 2004) and in the corresponding human adrenal disease, adrenal hyperplasia (Bourdeau et al., 2004) . Decreased complement expression (C1s) extends this conclusion to macrophages. In fact, unless corroborated otherwise, all such decreases should be considered with caution. In particular, the decreased expression of mRNAs corresponding to proteins involved in the TGFb signaling pathway in autonomous adenomas could perhaps be explained in this way (Eszlinger et al., 2004) . If this decrease in immune cell population reflects the in vivo situation rather than preferential cell loss from surgical samples, it might indicate that the growth of autonomous adenomas is not, like that of the thyroid in Graves disease, hampered by immunological reactions. Increased expression of genes of putative inhibitors of immune responses such as the chemokine CCL18 and FcGBP supports this hypothesis. Decreased blood cell markers (CD2 antigen, hemoglobin b and a2) also indicate lesser blood cells presence in the adenoma samples. The decreased population of lymphocytes and blood cells also possibly explains decreased expressions of quite a few genes: CXCL9, IL1RL1, BF and IL20RA. A genuine increase in the population of endothelial cells is suggested by the increased expression of endothelial specific genes (endothelial cell-specific molecule 1, connexin 37, von Willebrandt factor, NPR3) and by the decreased expression of inhibitors of angiogenesis, such as Thbs2, ADAMTS1, EDNRA and SerpinF1, indicating a higher vascularization of the tumor. The increased expression of N-cadherin could be interpreted in the same way, but we have shown by immunohistochemistry that this higher expression level is also found in the follicular cells themselves (Figure 5b) , suggesting that the increase affects the tumor cells. It is also found in human thyroid cancer cell lines (Husmark et al., 1999; unpublished data) . An increased capillary network is a correlate of follicle activity in human thyroids (Gerard et al., 2002) , of constitutive activation of the cAMP cascade in the thyrocytes of Tg-A2aR mice (Ledent et al., 1992) and of chronic stimulation of rat thyroids in vivo (Wollman et al., 1978) . It certainly explains the clinical observation of increased blood flow in autonomous adenomas. The mechanism of this effect of thyrocytes on endothelial cells remains to be defined, but some clues appear in our data. An increased expression of N-cadherin on thyrocytes would certainly enhance the contact between these cells and endothelial cells. Similarly, sialyltransferase1, whose expression is also increased, is proposed to increase cell adhesion to endothelial cells (Hanasaki et al., 1995) . Indeed, chronic stimulation of rat thyroids leads to a sponge-like aspect of the glands with follicles completely surrounded by capillaries and coated by a continuous sheet of endothelial cells (Wollman et al., 1978 (Wollman et al., , 1982 . Electron microscopies or image-directed Doppler sonography of autonomous adenomas are compatible with such a picture (Dralle and Bocker, 1977; Becker et al., 1997) . The increased expression of N-cadherin in autonomous adenomas which do not metastasize and which rarely evolve to carcinomas is a strong argument against the concept of N-cadherin as a marker for tumor cell invasion and metastasis (Rieger-Christ et al., 2004) . It would rather facilitate direct interaction of tumor and endothelial cells, which would lead to the capillarization of the autonomous adenomas, but could also be a primary step in the penetration of cancer cells in the vascular lumen. Decreased expression of genes coding for antiangiogenic proteins (Serpins, ADAMTS1) could also play a role in the endothelial expansion.
Caveolin I and II are considered as tumor suppressor genes and their decrease linked to metastasizing properties (Carver and Schnitzer, 2003) . Decreased caveolin expression has previously been observed in Tg-A2aR mice (Goffard et al., 2004) and has also been shown to be a characteristic of thyroid follicular carcinomas (Aldred et al., 2003 (Aldred et al., , 2004 . The decreased expression in autonomous adenomas, which are benign, noninvading tumors, certainly shows that, as for N-cadherin overexpression, underexpression of caveolins is not sufficient to confer a malignant phenotype and is not even a marker of malignancy. On the other hand, caveolins play a major antiproliferative role in endothelial cells, and, in Tg-A2aR mice, their decrease mostly bears on endothelial cells (Goffard et al., 2004) . This would be in agreement with the increased endothelial cell presence in the adenomas.
Our gene expression data suggest both a relative decrease of intracellular cytoskeletal proteins (myosin, gelsolin, MFAP4) and of proteins allowing adhesion to the extracellular matrix (laminin, fibulins, spondins, lumican, NELL2) . This would entail a previously unrecognized loosening of tissue and cell structure with unknown consequences.
Our data enlighten and explain several major physiological characteristics of the autonomous adenomas. A first important finding is the low proportion of genes with modified expression in the adenomas. The expression of the RNAs of most proteins corresponding to the basic machinery of the cell was not found to be significantly different in normal and adenomatous tissues, for example, proteins involved in protein synthesis, ribosomal proteins, etc. Signal transduction proteins were regulated in both directions with more genes downregulated than upregulated. The greater number of downregulated genes has been reported before (Eszlinger et al., 2001) . It can be related to the decrease in lymphocytic population and/or to a simplification of signal transduction in the tumor cell.
The low frequency of altered regulations already observed in autonomous adenomas (Eszlinger et al., 2001) and in Tg-A2aR mice (Goffard et al., 2004) reflects the physiology of such tumors. The metabolism of the adenomas is normal if stimulated. All this is consistent with the concept of a minimal deviation benign tumor: the cells are intrinsically stimulated, but their functional behavior is normal (Van Sande et al., 1988; Weber, 2002) . This has been further demonstrated by proteomic methodology (2D gels), by the virtual identity of both populations of proteins synthesized and phosphorylated in adenomatous and quiescent tissues (Van Sande et al., 1988) .
The known and clinically important increased functional activity can be related to increased expressions of thyroid-specific functional genes, like thyroperoxidase, deiodinase 1, rab3, metallothionein or sialyltransferase (Eszlinger et al., 2004) . Similarly, we found significant increased expression of syntaxin 7 (Wang et al., 1997) , and its cooperating partner SNAP25. Both proteins, as well as upregulated S100a1, may play a role in the activation of the thyroglobulin endocytic pathways, leading to thyroid hormone release. Increased thyroglobulin endocytosis and hormone secretion are observed in slices of autonomous adenomas (van den HoveVandenbroucke et al., 1976; Deleu et al., 2000) . Conversely, ANXA1, which is reported to inhibit secretion, is downregulated. Also, as expected in hyperactive cells, transporters (SLC25, SLC27) are upregulated. Upregulation of mitochondrial proteins (CKMT2, SLC25, MRPL1, CYP27B1) with no downregulation can also be related to increased functional activity. An increase in the number of mitochondria in these lesions has been demonstrated by electron microscopy (Hamburger et al., 1987) . No gene coding for a specific function protein is downregulated in our study.
The constitutive activation of the cAMP-dependent pathway in the adenomas stands in contrast with the barely increased cAMP levels in these cells (Van Sande et al., 1988) . The upregulation of phosphodiesterase PDE7B shown here as well as the weaker upregulations of PDE1B and PDE4D suggest a negative feedback on cAMP levels. An upregulation of phosphodiesterases by cAMP has been observed previously in thyroid cells in vitro as well as in other systems (Nilson et al., 1980; Persani et al., 2000) . Negative feedback in the adenoma cells is further provided by an upregulation of GRK5, which desensitizes the TSH receptor (Voigt et al., 2004) , and by a minor downregulation of adenylylcyclase (Eszlinger et al., 2004) . Cell heterogeneity and the great sensitivity of the cells to small cAMP rises (Neve and Dumont, 1970; Ketelbant-Balasse et al., 1976) might explain how the slightly increased averaged cAMP levels can sustain the increased activity and growth of thyrocytes.
The increased but still very low (0.8%) number of Ki-67-positive cells (Deleu et al., 2000; Eszlinger et al., 2004) correlates with the increased expression of mitogenic genes FGFR3, RbBP9) , as well as the decreased expression of antimitogenic genes (Thbs2, rarres3). These results provide clues about the mechanism involved. It is striking that different DUSP that inactivate MAP kinases (DUSP1, DUSP2, DUSP5) are downregulated, while another DUSP is upregulated (DUSP9). This might provide the cell with an increased background ERK activity that could account for the low but increased proliferation (Vandeput et al., 2003) . The general downregulation of immediate early genes (fos, fosB, egr-1, egr-2, junB, NGFIB, SRF) confirms some previous data obtained by Northern blotting in our group (Deleu et al., 2000) and in thyroid oncocytomas (Baris et al., 2004) . This result is not surprising, considering the low proportion of cells in the cell cycle as well as the necessary biphasic nature of the expression of these genes in the G1 phase of the cycle (Reuse et al., 1990; Pirson et al., 1994 Pirson et al., , 1996 . One candidate growth factor suggested to play a role in the growth of autonomous adenomas, IGF1, is contrary to expectations downregulated, while its inhibitor IGFBP1 is upregulated. This rather suggests, as in the case of the cAMP cascade, a negative feedback.
Autonomous adenomas are characterized by a low proliferation rate, but also by a virtual absence of apoptosis, as studied by the Tunel method (Deleu et al., 2000) . This can be related to the general downregulation of proapoptotic genes (JNK, clusterin, Gadd45a, NFKBIA, TRAIL, TP53BP2, ANXA1) also observed in the thyroids of Tg-A2aR mice and to the upregulation of antiapoptotic genes such as BIRC5.
Beside these general conclusions, the data offer additional clues to pursue on the physiopathology of the autonomous adenomas. FGF stimulates the proliferation of human thyroid cells (Roger and Dumont, 1984; Eggo et al., 1996) . The upregulation of FGFR3 could indicate a role of FGF in this disease. What is the role of upregulated FcGBP, of downregulated serpins and fibulins? These findings will be confirmed at the protein level and their biological meaning further investigated.
Materials and methods

Tissue samples
In all, 21 human thyroid samples were obtained after surgical resection from patients diagnosed for thyroid adenomas or multinodular goiter. Diagnosis was based on TSH serum levels, on the demonstration by scintigraphy of a highly radioactive nodule with poorly radioactive surrounding and contralateral tissue, and by post-surgical histological analysis demonstrating encapsulation. Tissues were immediately dissected, placed on ice, snap-frozen in liquid nitrogen and then stored at À801C until processing. The protocol received approval from the ethics committees of the institutions.
To validate the diagnosed identity of autonomous adenoma and their contralateral quiescent tissues, in a previous work (Van Sande et al., 1980) , slices of both had been incubated with radioiodide and methimazole to measure the iodide trapping (tissue to medium (T/M) ratio). This gave values of 0.7-1 in untreated patients, for the normal quiescent tissue, and largely above 1 for the adenomas. As some tissues were obtained from other institutions where no facility was available for these measurements, we relied in this study on the ratio of NIS mRNA expression in both tissues. The ratio of NIS mRNA expression was measured by real-time RT-PCR. In a series of Brussels samples, the correlation between the ratios of T/M and NIS mRNA expression between seven adenomas and quiescent tissue was R s ¼ 0.929 (Po0.003).
RNA purification
For RNA purification, frozen tissues (100-200 mg) were reduced to powder in liquid nitrogen, homogenized, and total RNA was extracted using a Trizol reagent kit (Life Technologies Inc.), followed by purification on Qiagen RNeasy columns. Concentration was assessed spectrophotometrically. RNA integrity was verified by visualization of intact 18S and 28S ribosomal RNA bands after gel migration. Typically, 15-90 mg total RNA was recovered by this procedure.
cDNA synthesis and labeling, microarray hybridization and detection Two different kinds of cDNA microarray slides were used. Analysis of the separated samples was performed on the Micromax Human cDNA microarray system (Perkin-Elmer Life Science, Boston, MA, USA), containing 2400 known human cDNA. Tumor RNA were hybridized together with patient-matched nontumoral RNA as described (Detours et al., 2005) . The second microarray analyses (pooled samples, analysis II) were performed on dual-channel human 5k microarrays (Microarray Facility, Flanders Interuniversity Institute for Biotechnology, Leuven, Belgium; http://www.microarrays.be). The human 5k slide set includes four slides onto which 18 442 ESTs representing 13 000 human genes are spotted in duplicate. The protocol used differs in several ways from the previous one. First, the RNA quality was additionally verified with a bioanalyzer (Agilent Technologies, Palo Alto, CA, USA). Second, antisense RNA amplification was performed before hybridization (using a modified protocol of in vitro transcription as published by Barry and Eberwine (Puskas et al., 2002) ). A pool of 10 mg of total RNA was amplified (about 200 Â ), purified with the RNeasy purification kit (Qiagen) and labeled with Cy3 or Cy5. The cDNA probes were directly labeled during the reverse transcription using 200 U Superscript II (Invitrogen) and anchored-oligodT primers.
Microarray scanning and data analysis
Micromax human cDNA microarrays (analysis I) were scanned on a GMS 418 (Affymetrix) array scanner and analysed using the ImaGene (BioDiscovery, Inc.) software and several in-house-developed software's. To increase the specificity of the results and bypass the inherent variability of the technique, each experiment was performed at least twice with dye switching and averaging of ratios. Prior to quantitative analysis, normalization was performed using the MatArray toolbox (Venet, 2003) . In short, the intensity dependence of the ratio was removed using a loess regression technique, as described in Yang et al. (2002) . Then the dependence of the ratio on the spot position was removed using a localizationdependent normalization. A cut-off value of 2 and statistical significance (Po0.05) was used to select up-or downregulated genes. We considered the median of the expression ratios among all the investigated samples.
The arrays from the Microarray Facility (analysis II) were scanned on a Generation III scanner (Amersham Pharmacia Biotech) and analysed using Array Vision (Imaging Research, Inc., St. Catharines, Ontario, Canada). Spot intensities were background corrected and filtered based on 2 s.d. above background. Ratios were normalized by a linear regression between log 10 ratio (Cy5/Cy3) and log 10 total intensity of Cy5 Â Cy3. From duplicate spots, average ratios Cy5/Cy3 were used for further analysis. Only the spots with an average ratio greater than 3 in both hybridizations were retained for further analysis. Some potentially interesting genes with a smaller average ratio were also retained because their differential expression was confirmed by RT-PCR.
Real-time RT-PCR
Real-time RT-PCR was performed as described in Detours et al. (2005) . Oligonucleotide sequences corresponding to the selected transcripts were designed using Primer Express software (Applied Biosystems, CA, USA). The nucleotide sequences are available upon request. Relative quantifications of gene expression were performed with the ABI Prism 7700 Sequence Detection System (AB/Perkin-Elmer). For calculating the expression level, we determined the relative quantification of a target gene in comparison to a reference gene (PBGD or CNAP1) based on the PCR efficiencies of each gene and the C t (threshold cycle) deviation of an unknown sample versus a control (tumor sample versus adjacent quiescent tissue sample). (Pfaffl, 2001 ). All the real-time RT-PCR experiments were performed in duplicate or triplicate.
Ratio
Gel electrophoresis and immunodetection of proteins
Frozen tissues were reduced to powder and homogenized in 200-500 ml of lysis buffer composed of Laemmli buffer 2 Â , 1 mg/ml aprotinin, 1 mg/ml leupeptin and 60 mg/ml pefabloc, boiled for 5 min and frozen in liquid nitrogen. The total cellular proteins obtained were separated according to their molecular mass by SDS-PAGE (10% gel) and immunodetected as described (Baptist et al., 1995) with rabbit polyclonal antibodies against cav1 (dilution 1/5000) (BD Biosciences, CA, USA), mouse monoclonal anti-N-cadherin antibodies (dilution 1/500) (Zymed Laboratories Inc., CA, USA) or mouse monoclonal anti-adaptin b antibodies (dilution 1/2000) (BD Biosciences, CA, USA). Anti-mouse and anti-rabbit immunoglobulin secondary antibodies (Amersham), both coupled to horseradish peroxidase, were used for detection by enhanced chemiluminescence (Western Lightning, Perkin-Elmer Life Sciences).
Immunohistochemistry
A total of 10 formalin-fixed, paraffin-embedded thyroid adenoma samples and their normal counterparts (five adenomas, five normal thyroid counterparts) were used for tissue microarray construction, as described (Kononen et al., 1998) . Each case comprised a triplet of tumor tissue in addition to a triplet of the normal counterpart. A total of 30 spots of 0.6 mm diameter were available for the study. Immunostaining was performed using the standard avidin-biotin peroxidase technique with antigen retrieval, in accordance with the studied antibody. The primary antibodies were: anti-N-cadherin, dilution 1 : 500 (Zymed Laboratories Inc., San Francisco, USA), anti-caveolin 1 (N-20) : sc-894, dilution 1 : 400 (Santa Cruz Biotechnology).
Diaminobenzidin was used as the chromogen and hematoxylin as the nuclear counterstain. For negative controls, the primary antibody was either omitted or replaced by a suitable concentration of normal IgG of the same species.
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